Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferhan Qureshi

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|July 4, 2012
Characterization of a multiplex, 12-biomarker test for rheumatoid arthritisP Scott Eastman, William C Manning, Ferhan Qureshi, et al.
International Journal of MS Care|March 26, 2025
Proteomic Biomarker Panel for Gauging Multiple Sclerosis Disease Activity: A Case Series From Real-World UseTaylor Gonyou, Patricia Izbicki, Jim Eubanks, et al.
Multiple Sclerosis and Related Disorders|October 11, 2025
Proteomics confirms immune stabilizing effects of narrowband UVB treatment in patients with clinically isolated syndrome and multiple sclerosisPrue H Hart, Christopher J Emig, Ahmed Z Obeidat, et al.
Journal of Immunological Methods|February 28, 2012
Pre-analytical effects of blood sampling and handling in quantitative immunoassays for rheumatoid arthritisXiaoyan Zhao, Ferhan Qureshi, P Scott Eastman, et al.
Biomolecules|July 27, 2024
Serum Biomarker Signatures of Choroid Plexus Volume Changes in Multiple SclerosisDejan Jakimovski, Robert Zivadinov, Ferhan Qureshi, et al.
Journal of the Neurological Sciences|May 18, 2024
Glial cell injury and atrophied lesion volume as measures of chronic multiple sclerosis inflammationDejan Jakimovski, Ferhan Qureshi, Murali Ramanathan, et al.
Brain Communications|January 9, 2024
Association between serum multi-protein biomarker profile and real-world disability in multiple sclerosisWen Zhu, Chenyi Chen, Lili Zhang, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 11, 2026
High-dose <i>N</i>-acetyl cysteine reduces GFAP levels: Exploratory results from a pilot double-blind, placebo-controlled randomized trialVinicius A Schoeps, Raviola Murataj, Akash Virupakshaiah, et al.
British Journal of Pharmacology|July 19, 2006
Preclinical pharmacokinetics, pharmacodynamics, and activity of a humanized anti-CD40 antibody (SGN-40) in rodents and non-human primatesSean K Kelley, Thomas Gelzleichter, Dong Xie, et al.
Brain Communications|June 26, 2023
Proteomics and relationship with axonal pathology in multiple sclerosis: 5-year diffusion tensor imaging studyDejan Jakimovski, Ferhan Qureshi, Murali Ramanathan, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Journal of Pharmaceutical and Biomedical Analysis|July 4, 2012
Characterization of a multiplex, 12-biomarker test for rheumatoid arthritisP Scott Eastman, William C Manning, Ferhan Qureshi, et al.
International Journal of MS Care|March 26, 2025
Proteomic Biomarker Panel for Gauging Multiple Sclerosis Disease Activity: A Case Series From Real-World UseTaylor Gonyou, Patricia Izbicki, Jim Eubanks, et al.
Multiple Sclerosis and Related Disorders|October 11, 2025
Proteomics confirms immune stabilizing effects of narrowband UVB treatment in patients with clinically isolated syndrome and multiple sclerosisPrue H Hart, Christopher J Emig, Ahmed Z Obeidat, et al.
Journal of Immunological Methods|February 28, 2012
Pre-analytical effects of blood sampling and handling in quantitative immunoassays for rheumatoid arthritisXiaoyan Zhao, Ferhan Qureshi, P Scott Eastman, et al.
Biomolecules|July 27, 2024
Serum Biomarker Signatures of Choroid Plexus Volume Changes in Multiple SclerosisDejan Jakimovski, Robert Zivadinov, Ferhan Qureshi, et al.
Journal of the Neurological Sciences|May 18, 2024
Glial cell injury and atrophied lesion volume as measures of chronic multiple sclerosis inflammationDejan Jakimovski, Ferhan Qureshi, Murali Ramanathan, et al.
Brain Communications|January 9, 2024
Association between serum multi-protein biomarker profile and real-world disability in multiple sclerosisWen Zhu, Chenyi Chen, Lili Zhang, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 11, 2026
High-dose <i>N</i>-acetyl cysteine reduces GFAP levels: Exploratory results from a pilot double-blind, placebo-controlled randomized trialVinicius A Schoeps, Raviola Murataj, Akash Virupakshaiah, et al.
British Journal of Pharmacology|July 19, 2006
Preclinical pharmacokinetics, pharmacodynamics, and activity of a humanized anti-CD40 antibody (SGN-40) in rodents and non-human primatesSean K Kelley, Thomas Gelzleichter, Dong Xie, et al.
Brain Communications|June 26, 2023
Proteomics and relationship with axonal pathology in multiple sclerosis: 5-year diffusion tensor imaging studyDejan Jakimovski, Ferhan Qureshi, Murali Ramanathan, et al.
Pageof 3